Comparison of CoCr Alloy and TiN Coating in TKA

Sponsor
Medical University of Graz (Other)
Overall Status
Recruiting
CT.gov ID
NCT04701359
Collaborator
Alphamed Medizintechnik Fischer GmbH (Other)
200
1
2
84.7
2.4

Study Details

Study Description

Brief Summary

In the current prospective, randomized study, two different materials of the same total knee arthroplasty (TKA) system - cobalt-chromium (CoCr) and titanium-nitride (TiN) - are going to be compared with regards to postoperative outcome. Two-hundred patients are planned to be included in the study over a 4-year period, randomly assigned to either the CoCr- or TiN-implant-group. In order to ensure double-blinding, patients will not be informed about the group they had been assigned to. Moreover, no identifying information of the implant used will be written on documents later accessible to nurses and/or physicians at follow-up appointments. Consequently, surgeons of the respective patients will be excluded from study-specific examination of patients. Despite range of motion (ROM), questionnaires (visual analogue scale - VAS; Western Ontario and McMaster Universities Osteoarthritis Index - WOMAC, Forgotten Joint Score - FJS; Knee Society Scoe - KSS) will be used to assess the postoperative outcome. Furthermore, metal ion levels (cobalt, chrom, molybdenum, titanium) in the blood stream of patients will be measured at scheduled follow-up appointments. It is expected that there will not be a measureable difference between the two coating-groups with regards to ROM, functionality, and metal-ion levels over time.

Condition or Disease Intervention/Treatment Phase
  • Device: TiN-alloy based total knee arthroplasty
  • Device: CoCr-coating based total knee arthroplasty
N/A

Detailed Description

Rationale

The present double-blinded study was planned in order to assess whether differences in materials - using one otherwise similar TKA system - would have an effect on postoperative patient outcome. Moreover, metal ion levels will be measured in the blood stream preoperatively (as reference) and upon follow-up, based on previous observations that metal ion levels are increased in serum following TKA, without any relevant influence on outcome.

Aims

The aim of the present prospective study is to assess whether differences in tribological pairings - i.e. TiN-coating in comparison to CoCr-alloy using a frequently implanted total knee endoprosthesis (ACS® System, Implantcast GmbH, Buxtehude, Germany) - have an effect on postoperative range of motion (ROM) and patient satisfaction, reflected by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Forgotten Joint Score (FJS), Knee Society Score (KSS), Visual Analogue Scale (VAS). Moreover, metal ion levels will be tested in both groups to monitor their concentration in the blood stream, usually reflecting physiological abrasion.

Endpoints

The primary endpoint of the current study is the functional outcome of patients with TKA on a CoCrMo- basis in comparison to a TiN-coated implant. The secondary endpoint is the measurement of metal ion levels in the blood stream and their potential dynamics over time.

Methods

Two-hundred patients will be prospectively included in the study over a 4-year period, with 100 being randomly assigned to group A (TiN-coating) and 100 to group B (CoCr-alloy).

Random assignment will be carried out via an automatic randomisation system run by a local study nurse. Pre- and postoperatively, range of motion (ROM), visual analogue scale (VAS) score and specific questionnaires - i.e. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Forgotten Joint Score (FJS), Knee Society Score (KSS) - will be ascertained (Table 1) in order to allow comparison of potential differences between group A and B during follow-up. Furthermore, preoperatively, at 6 months, 12 months, 24 months and 60 months, metal ion levels (cobalt, chromium, molybdenum, titanium) in the blood stream will be measured in each patient (6ml tubes). Measurements of metal ion levels will be performed at an external institution.

The phase of active recruiting is planned for 4 years, with 50 patients being included per year on average. With the last patients anticipated to being included at the end of the 4th year, their follow-up will be finished 9 years after study initiation.

Randomisation and Blinding

All patients will be informed prior to potential study participation whether or not to they would like to participate, clarifying that refusal will not have any negative impact on further treatment. In case patients agree to participate, they will be randomly assigned to either group A or B.

Double-blinding will be made possible by not informing patients whether they had been allocated to group A or B and by not directly revealing information about the implant type used on medical records that will later be accessible to the study nurse and/or physicians during clinical examinations at follow- up. Therefore, it will be necessary to exclude those surgeons participating in the surgeries of the respective patients from examining them during follow-up, in order to maintain blinding. Prior to follow-up appointments, surgeons who had not participated in surgeries of the respective patients will thus be informed by the study nurse in order to perform clinical examination, radiological follow-up and questionnaires.

Expected Results

As patients receive the identical orthopaedic implant during an identical surgical procedure for comparable indications, it is expected that the differences in alloy (i.e. TiN vs. CoCr) will not have a measurable effect on postoperative patient outcome. Neither there is expected to be a difference in metal ion levels in the blood stream over time between groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-hundred patients with knee osteoarthritis included altogether. Patients randomly assigned to group A (receiving total knee arthroplasty [TKA] with TiN-coating) or group B (receiving TKA with CoCr-alloy).Two-hundred patients with knee osteoarthritis included altogether. Patients randomly assigned to group A (receiving total knee arthroplasty [TKA] with TiN-coating) or group B (receiving TKA with CoCr-alloy).
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Masking of both patients and outcome assessors. Only care provider (i.e. surgeon) and investigator aware of implant-type used. During follow-up, neither care provider nor investigator allowed to assess patients' study-specific outcome. As implants look identical on X-rays, allocation to one or another group cannot be verified by independent outcome assessors.
Primary Purpose:
Treatment
Official Title:
Comparison of Cobalt-Chromium (CoCr) Alloy and Titanium-Nitride (TiN) Coating in Total Knee Arthroplasty: A Prospective, Randomised, Double-blinded Clinical Trial
Anticipated Study Start Date :
Oct 10, 2022
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Nov 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A (TiN-coating)

Patients with knee osteoarthritis receive total knee arthroplasty with Titanium-Nitride (TiN)-coated implant.

Device: TiN-alloy based total knee arthroplasty
TiN-alloy based TKA implanted for knee osteoarthritis.
Other Names:
  • ACS System, Implantcast GmbH, Buxtehude, Germany
  • Active Comparator: Group B (CoCr-alloy)

    Patients with knee osteoarthritis receive total knee arthroplasty with Cobalt-Chromium (CoCr)-alloy implant.

    Device: CoCr-coating based total knee arthroplasty
    CoCr-coating based TKA implanted for knee osteoarthritis.
    Other Names:
  • ACS System, Implantcast GmbH, Buxtehude, Germany
  • Outcome Measures

    Primary Outcome Measures

    1. Change of Postoperative functional outcome - ROM with goniometer [Preoperatively, postoperative week 6, month 12, month 24, month 60.]

      Range of motion (ROM), assessed with goniometer approved for medical issues

    2. Change of Postoperative functional outcome - pain [Preoperatively, postoperative week 6, month 12, month 24, month 60.]

      VAS score (Visual Analogue Scale; 0 = no pain, 10 = severe pain)

    3. Change of Postoperative functional outcome - Western Ontario and McMaster Universities Arthritis Index (WOMAC) [Preoperatively, postoperative week 6, month 12, month 24, month 60.]

      Assessed by Western Ontario and McMaster Universities Arthritis Index (WOMAC). This index ranges from 0 to 100 points and is based on items pain, physical function and joint stiffness. Lower values indicating better outcomes, whilst higher values point towards worse outcome. Higher scores on the WOMAC indicate a worse outcome

    4. Change of Postoperative functional outcome - FJS [Preoperatively, postoperative week 6, month 12, month 24, month 60.]

      Forgotten Joint Score (FJS) with a scale ranging from 0 to 100, where a high value indicates a better outcome

    5. Change of Postoperative functional outcome - Knee Society Score (KSS) [Preoperatively, postoperative week 6, month 12, month 24, month 60.]

      Knee society score (KSS) is built up by two scores, i.e. "Functional Score" (3 items) and "Knee Score" (7 items), both ranging from 0 to 100 points. The lower the values, the worse the outcome.

    Secondary Outcome Measures

    1. Change of Metal ion levels in blood stream [Preoperatively, month 6, month 12, month 24, month 60.]

      Measurement of titanium, cobalt, chromium, molybdenum in blood stream at specific time-points.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Knee osteoarthritis of index knee

    • Varus angle < 15° of index knee

    Exclusion Criteria:
    • Previous native knee infection of index knee

    • Previous distal femoral fracture of index knee

    • Previous proximal tibial fracture of index knee

    • Preceding osteotomy of index knee

    • Known allergies against metals, drugs, organic substances

    • Unicondylar prosthetic replacement of index knee

    • Knee osteoarthritis of both joints with planned simultaneous TKA

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Orthopaedics and Trauma, Medical University of Graz, Austria Graz Austria 8036

    Sponsors and Collaborators

    • Medical University of Graz
    • Alphamed Medizintechnik Fischer GmbH

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Medical University of Graz
    ClinicalTrials.gov Identifier:
    NCT04701359
    Other Study ID Numbers:
    • 1533/2020
    First Posted:
    Jan 8, 2021
    Last Update Posted:
    Apr 8, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Medical University of Graz
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 8, 2022